Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 29:2018:4197857.
doi: 10.1155/2018/4197857. eCollection 2018.

Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis

Kyeong-Ah Kwak  1 , Hyun-Jae Cho  2 , Jin-Young Yang  3 , Young-Seok Park  1
Affiliations
Review

Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis

Kyeong-Ah Kwak et al. Can J Gastroenterol Hepatol. .

Abstract

Liver cirrhosis is a major cause of mortality and a common end of various progressive liver diseases. Since the effective treatment is currently limited to liver transplantation, stem cell-based therapy as an alternative has attracted interest due to promising results from preclinical and clinical studies. However, there is still much to be understood regarding the precise mechanisms of action. A number of stem cells from different origins have been employed for hepatic regeneration with different degrees of success. The present review presents a synopsis of stem cell research for the treatment of patients with liver cirrhosis according to the stem cell type. Clinical trials to date are summarized briefly. Finally, issues to be resolved and future perspectives are discussed with regard to clinical applications.

PubMed Disclaimer

References

    1. Eom Y. W., Shim K. Y., Baik S. K. Mesenchymal stem cell therapy for liver fibrosis. Korean Journal of Internal Medicine. 2015;30(5):580–589. doi: 10.3904/kjim.2015.30.5.580. - DOI - PMC - PubMed
    1. Bataller R., Brenner D. A. Liver fibrosis. The Journal of Clinical Investigation. 2005;115(2):209–218. doi: 10.1172/JCI200524282. - DOI - PMC - PubMed
    1. Domitrović R., Jakovac H. Effects of standardized bilberry fruit extract (Mirtoselect®) on resolution of CCl4-induced liver fibrosis in mice. Food and Chemical Toxicology. 2011;49(4):848–854. doi: 10.1016/j.fct.2010.12.006. - DOI - PubMed
    1. Ghatak S., Biswas A., Dhali G. K., Chowdhury A., Boyer J. L., Santra A. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicology and Applied Pharmacology. 2011;251(1):59–69. doi: 10.1016/j.taap.2010.11.016. - DOI - PMC - PubMed
    1. Hong W. K., Kim M. Y., Baik S. K., et al. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clinical and Molecular Hepatology. 2013;19(4):370–375. doi: 10.3350/cmh.2013.19.4.370. - DOI - PMC - PubMed

MeSH terms